Immatics N.V. (IMTX) vs Vor Biopharma Inc. (VOR)
A side-by-side comparison of Immatics N.V. and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMTX
Immatics N.V.
$7.53HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
VOR
Vor Biopharma Inc.
$18.44HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — IMTX vs VOR
growth of $100 · dividends reinvested · last 6yIMTX -28.8% (-5.5%/yr)VOR -97.5% (-46.0%/yr)IMTX compounded faster over this window
Log scale — wide-divergence pair
IMTX VOR
IMTX vs VOR: by the numbers
- •IMTX is the larger company ($1.01B vs $999M market cap).
- •Both run net losses; VOR's is the smaller (0.00% vs -493.26% net margin).
Metrics side by side
Valuation
| Metric | IMTX | VOR |
|---|---|---|
| P/S ratio | 20.80 | N/A |
| P/B ratio | 2.21 | N/A |
Profitability
| Metric | IMTX | VOR |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -377.11% | 0.00% |
| Net margin | -493.26% | 0.00% |
| ROE | -52.47% | N/A |
| ROIC | -53.36% | -32.24% |
Growth (annualized)
| Metric | IMTX | VOR |
|---|---|---|
| Revenue CAGR (5Y) | 6.40% | N/A |
| Total return CAGR (5Y) | -9.88% | -42.54% |
Frequently asked
- How have IMTX and VOR total returns compared?
- Over the past 5 years, IMTX delivered -9.88% and VOR delivered -42.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.